openPR Logo
Press release

Ventilator-associated pneumonia (VAP) Market 2018 - Major Players are Merck & Co., Inc. (US), Adenium Biotech ApS (Denmark) and more.

03-05-2018 07:23 AM CET | Health & Medicine

Press release from: Market Research Future

Market Research Future

Market Research Future

Ventilator-associated pneumonia Market Report is added on Marketresearchfuture.com with 80 pages. The reports also covers brief analysis of Market Structure, Assumptions & Limitations, Research Process, Opportunities, and Porter’s Five Forces Model, Global Ventilator-associated pneumonia Market (By Indications, Type, Application, and Regions), Company Landscape, Company Profile and Worldwide Forecast to 2022

Global Ventilator-associated pneumonia (VAP) market has been segmented on the basis of diagnosis which includes clinical, radiological, and microbiological and others. On the basis of end users which consists of hospitals, clinics, research facilities and others. On the basis of mode of treatment home care, hospital care and others.

Get Sample copy of Ventilator-associated pneumonia Market Report@ https://www.marketresearchfuture.com/sample_request/1377 .

Key Players for Ventilator-associated pneumonia (VAP) Market:

Some of the key players in this market are: Merck & Co., Inc. (US), Adenium Biotech ApS (Denmark), AstraZeneca (UK), MedImmune (US), Nabriva Therapeutics AG (Austria).

Global Ventilator-associated Pneumonia (VAP) Market - Overview

Patients in critical care require aid for respiration. Many of them suffer from disease like heart disease which require continuous monitoring by healthcare staff in intensive care unit. Ventilator- associated pneumonia is prevalent among patients admitted to ICUs. It is a significant cause of morbidity and mortality in ICU. This disease results from contaminated pathogen secretions in the lungs. Prolonged use of ventilators in ICU favour the growth of this market. Increase in hospital acquired infection is also another factor contributing for the growth of this market. Prevention of ventilator-associated pneumonia is important to protect the health of patients suffering from life threating diseases.

Get Discount on Ventilator-associated pneumonia Market Report @ https://www.marketresearchfuture.com/check-discount/1377 .

Global Ventilator-associated pneumonia (VAP) market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.

Global Ventilator-associated Pneumonia (VAP) Market - Competitive Analysis

June, 2016 - AstraZeneca had announced that the European Commission (EC) has granted marketing authorisation for Zavicefta, which a combination antibiotic for the treatment of patients with serious Gram-negative bacterial infections requiring hospitalisation. AstraZeneca is a global, innovation-driven biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas which are respiratory, inflammation, autoimmune disease (RIA), cardiovascular and metabolic disease (CVMD) and oncology and infection and neuroscience. Company operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. As per company reports, hospital-acquired pneumonia (HAP) denotes the development of lung infections after a patient has been hospitalised for a minimum of 48 hours.

Global Ventilator-associated pneumonia (VAP) Market   - Regional Analysis

Globally, Ventilator-associated pneumonia (VAP) market consists of four regions Americas, Europe, Asia Pacific and Middle East & Africa. America is the largest market for Ventilator-associated pneumonia (VAP) whose growth is contributed to increase in prevalence of smoking leading to lung diseases, large number of patients suffering from chronic heart diseases and demand of mechanical ventilators. The market is growing continuously in Europe due to extensive demand of medical devices in hospitals, and increasing healthcare expenditure. Asia Pacific is expected to be the fastest growing market owing to increase in environmental pollution, high incidence of asthma & chronic obstructive pulmonary disease and large patient pool. Moreover, Awareness regarding prevention of hospital acquired infection, pneumonia and quality control measures taken by hospitals for control of nosocomial infection favour the growth of this market. Increasing ageing population and incidence of infectious disease too contribute for the growth of this market in Asia Pacific. On the other hand, the Middle East & Africa region are likely to have a limited but steady growth in the market.

Browse Complete Report and in-depth TOC @ https://www.marketresearchfuture.com/reports/ventilator-associated-pneumonia-vap-market-1377 .

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Ventilator-associated pneumonia (VAP) Market 2018 - Major Players are Merck & Co., Inc. (US), Adenium Biotech ApS (Denmark) and more. here

News-ID: 963752 • Views:

More Releases from Market Research Future

Americas Recycled Plastics Market: Opportunities For Higher Growth| Delta Plastics, UltrePET, Biocirculo
Americas Recycled Plastics Market: Opportunities For Higher Growth| Delta Plasti …
Global Americas Recycled Plastics Market Report from Market Research Forecast highlights deep analysis on market characteristics, sizing, estimates and growth by segmentation, regional breakdowns & country along with competitive landscape, player's market shares, and strategies that are key in the market. The exploration provides a 360° view and insights, highlighting major outcomes of the industry. These insights help the business decision-makers to formulate better business plans and make informed decisions
Hydrofluoric Acid Market (CAGR) of 4%, Innovation Imperative Future Proofing Your Business with Market Size
Hydrofluoric Acid Market (CAGR) of 4%, Innovation Imperative Future Proofing You …
Hydrofluoric acid (HF) is a crucial chemical compound with a wide range of applications across various industries. Despite its hazardous nature, it plays an essential role in manufacturing processes, especially in the production of fluorine compounds. The global hydrofluoric acid market has been witnessing steady growth, driven by demand from end-user industries such as oil refining, pharmaceuticals, and electronics. The Hydrodesulfurization Catalysts Market is projected to register a CAGR of over
Palm Methyl Ester Derivative Market Size Projected to Grow at 5.92% CAGR, Reaching USD 2.4 billion by 2030
Palm Methyl Ester Derivative Market Size Projected to Grow at 5.92% CAGR, Reachi …
In recent years, the global market for palm methyl ester derivatives has witnessed significant growth, driven by various factors including environmental concerns, technological advancements, and the increasing demand for sustainable alternatives in various industries. Palm methyl ester derivatives, derived from palm oil, have emerged as versatile ingredients with applications spanning across sectors such as cosmetics, pharmaceuticals, lubricants, and more. The Palm Methyl Ester Derivative Market Size was valued at USD 1.5
Asia-Pacific Ceramic Tiles Market to Register Highest CAGR Growth of 7.50% by 2032: Analysis by Segmentation, Competitors Analysis
Asia-Pacific Ceramic Tiles Market to Register Highest CAGR Growth of 7.50% by 20 …
The Asia-Pacific ceramic tiles market has been witnessing robust growth, driven by various factors such as increasing investments in residential and commercial construction, renovation activities, and the growing preference for aesthetically pleasing and durable flooring solutions. Countries like China, India, Japan, and South Korea have been leading the market growth, supported by strong manufacturing capabilities, technological advancements, and evolving consumer preferences. Asia-Pacific Ceramic Tiles Market Size was valued at USD 141.2

All 5 Releases


More Releases for VAP

Ventilator-associated Pneumonia (VAP) Market: Increase in Hospital Acquired in I …
Ventilator associated pneumonia (VAP) is an intensive care unit (ICU) for acquired infection. This pulmonary infection generally occurs 48 hours after a patient is incubated and has received mechanical ventilation. Incidence of VAP ranges from 6% to 55% and can reach up to 76% in some situations. VAP is a major cause of illness and death. Patients suffering with VAP have increased spans of ICU hospitalization. Moreover, death rate has
Ventilator Associated Pneumonia (VAP) Market size, Share, Growth & Forecast 2026
Ventilator Associated Pneumonia (VAP) Market Overview: 2026 This report focuses on the global Ventilator Associated Pneumonia (VAP) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Ventilator Associated Pneumonia (VAP) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. Inquire For Sample: https://reports.valuates.com/request/sample/QYRE-Auto-10Z1992/Global_Ventilator_Associated_Pneumonia_VAP_Market The key players covered in this study Philips Respironics Hoffrichter
Expanding Worldwide Market of Ventilator Associated Pneumonia (VAP) Research rep …
The Ventilator Associated Pneumonia (VAP) industry report examines marked growth trends and technological developments that will come to the fore in the said Ventilator Associated Pneumonia (VAP) market in the coming years. In addition, the Ventilator Associated Pneumonia (VAP) market report includes historical growth markers, competitive hierarchy, and development trends and data about how these indices will change in the regional and international markets in the coming years. For a detailed
Germany Ventilator Associated Pneumonia (VAP) Therapeutics Market Status and Out …
A fresh report has been added to the wide database of Market Research Hub (MRH) titled “Germany Ventilator Associated Pneumonia (VAP) Therapeutics Market Research Report 2018” which provides an outlook for current market value as well as the expected forecast including Rate on Investment (ROI) together with growing CAGR of XX% during 2018-2022. This report studies the Ventilator Associated Pneumonia (VAP) Therapeutics development status and future trend in Germany, focuses
Ventilator Associated Pneumonia (VAP) Therapeutics Market 2017- Bayer AG, Achaog …
Apex Market Reports, recently published a detailed market research study focused on the "Ventilator Associated Pneumonia (VAP) Therapeutics Market" across the global, regional and country level. The report provides 360° analysis of "Ventilator Associated Pneumonia (VAP) Therapeutics Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Ventilator Associated Pneumonia (VAP) Therapeutics industry,
Ventilator Associated Pneumonia (VAP) - Pipeline Review, H2 : Pharmaceuticals In …
Market Research Hub's latest Pharmaceutical and Healthcare disease pipeline guide “Ventilator Associated Pneumonia Pipeline Review”, H2 2017, provides an overview of the Ventilator Associated Pneumonia (VAP) (Infectious Disease) pipeline landscape. Ventilator-associated pneumonia (VAP) is pneumonia that develops 48 hours or longer after mechanical ventilation is given by means of an endotracheal tube or tracheostomy. Ventilator-associated pneumonia (VAP) results from the invasion of the lower respiratory tract and lung parenchyma by microorganisms.